Podcast Episodes
Back to Search
How your gut microbiome could influence Multiple Sclerosis with Prof. Dr. Natalia Szejko
Season 1 Episode 79
Dr. Natalia Szejko reveals latest research on gut microbiome for MS, MOGAD, and NMOSD, offering new hope for managing these conditions.
You can read …
1 year, 10 months ago
Cladribine (Mavenclad, Leustat, Litak) for highly active MS
Season 1 Episode 78
Cladribine (Mavenclad, Leustat, Litak) is an induction therapy the supresses the immun system and is used for highly active MS.
You can read the comp…
1 year, 11 months ago
Tailoring MS Treatment. The Impact of Mood Disorders on Patient Care with Dr. Emine Rabia Koç
Season 1 Episode 77
Explore Dr. Emine Rabia Koç's insights on blending emotional and physical health for a holistic approach to MS treatment.
You can find the written ve…
1 year, 11 months ago
Alemtuzumab (Lemtrada, Campath) for highly active relapsing MS
Season 1 Episode 76
Alemtuzumab (Lemtrada, Campath) is a DMT to treat highly active MS and has long-lasting effects and potential severe side effects.
You can read the f…
1 year, 11 months ago
Decoding the EDSS Score. How It's Measured and What It Means
Season 1 Episode 75
The EDSS score helps neurologists to measure the progression of MS as it measures limitations in functional systems.
You can find the full article at…
1 year, 11 months ago
#074: S1P Modulators - Fingolimod (Gilenya), Ozanimod (Zeposia), Ponesimod (Ponvory), Siponimod (Mayzent) for active RRMS & SPMS
Season 1 Episode 74
Learn more about the S1P Modulators, known by the brand names Gilenya, Zeposia, Ponvory, Mayzent and their usage against active RRMS & SPMS.
You can …
1 year, 11 months ago
#073: "Haciendo Lo Invisible, Visible". Crys's Journey of Invisible Battles and Visible Triumphs as Latina with MS in the US
Season 1 Episode 73
Crys was diagnosed with MS at the age of 11. She talks about her experiences as a first-generation Latina and her mission on social media. You can fi…
2 years ago
Natalizumab (Tysabri, Tyruko) for active relapsing remitting MS
Season 1 Episode 72
Natalizumab (Tysabri, Tyruko) is approved as disease-modifying therapy (DMT) for active RRMS with a rapidly evolving severe MS.
You can read the comp…
2 years ago
Insights into MS treatment in Colombia with neurologist Dr. Adriana Casallas Vanegas
Season 1 Episode 71
Dr. Adriana Casallas V. provides insights into the treatment and care of MS patients in Colombia including improvements and challenges.
You can find …
2 years ago
Teriflunomide (Aubagio) for relapsing remitting MS
Season 1 Episode 70
Teriflunomide (Aubagio) is approved as disease-modifying therapy for mild to moderate RRMS from 10 years of age.
You can find the full article to rea…
2 years ago